N/A N=52 Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
Type 1 Diabetes Mellitus
Primary: Hemoglobin A1c — 7.988; 8.025 A1c percentage
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=114 New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Diabetes Mellitus, Type 1
Primary: Mean Stimulated C-peptide Area Under the Curve — 0.28; 0.27; 0.25 pmol/ml — p=0.47
N/A N=34 Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Diabetes Remission Rate — 3; 6 Participants — p=<0.0001
N/A N=23 Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
Type 2 Diabetes
Primary: Peak Oxygen Consumption (VO2 Peak) — 16.6; 16.1 milliliters per kilogram per minute
N/A N=259 Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)
Severe Hypoglycemia
Primary: Self-reported Severe Hypoglycemia — 99; 99; 19; 13 Participants — p=0.27
N/A N=79 Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
Primary: Self-Care Activities: Healthy Eating — 4.23; 4.67; 4.61; 4.60 days/week (min: 0 days; Max: 7 days)
Phase 3 N=28 Adjunctive Metformin Therapy in Double Diabetes
Diabetes Mellitus
Primary: Baseline Adjusted Hemoglobin A1c Over Time — 9.46; 9.85 percentage of HbA1c — p=0.903
N/A N=10 Salsalate for Insulin Resistance in Schizophrenia
Schizophrenia · Insulin Resistance
Primary: Side Effects of Salsalate — 3 participants
Phase 3 N=560 Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
Primary: Rate of Type 1 Diabetes Per Year Among Individuals in the Primary Stratum When Treated With Oral Inulin Versus Placebo — 0.088; 0.102 Proportion with diabetes/year
N/A N=96,759 Impact of Medicaid Health Home on Patients With Diabetes in New York City
Type 2 Diabetes Mellitus
Primary: Number of Enrollees With Diabetes-related Preventable Hospitalizations — 48; 109; 48; 90 Participants
N/A N=62 A Comparison Chocolate With and Without High Cocoa Solids in Patients With Type 2 Diabetes in a Randomised Clinical Trial
Diabetes Type 2
Primary: Difference in Insulin Resistance (HOMA) Between Treatments After 12 Weeks of Product Intake — 2.82; 2.21; 2.75 HOMA index
Phase 3 N=69 Liraglutide in Type 1 Diabetes
Type 1 Diabetes
Primary: HbA1c (%) — 7.92; 7.48; 7.45; 7.58 Percent of Hemoglobin (%)
Phase 4 N=104 The Health Influences of Puberty (HIP) Study
Obesity · Insulin Resistance · Gonadal Dysfunction
Primary: Insulin Sensitivity — 8.559; 3.425; 3.756; 2.985 x10-4/min-1/mIU/mL
Phase 4 N=44 Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
Diabetes Mellitus, Type 2 · Diabetic Nephropathies
Primary: Glomerular Filtration Rate (GFR) in ml/Min — 104; 109 ml/min
Phase 3 N=5 Liraglutide in Adolescents With Type 1 Diabetes
Type 1 Diabetes
Primary: Mean Weekly Blood Glucose — 187; 178 mg/dL